Mellitus
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(617) 758-4146Website
www.mellitusllc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Mellitus
Mellitus is a private company that was founded to develop and commercialize a novel in vitro diagnostic assay for the measurement of Glycated CD59 (GCD59). GCD59 may provide information about glycemic control, with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk, and as a companion diagnostic for pharmaceutical development. Mellitus' lead product candidate is an in vitro diagnostic assay for Gestational Diabetes Mellitus (GDM). The GCD59 technology is based on research conducted by Drs. Jose Halperin and Michael Chorev at Harvard Medical School. The technology is part of a patent portfolio exclusively licensed to Mellitus. Mellitus is located in Cambridge, Massachusetts.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mellitus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Mellitus
Earning: See what the market has to say on Mellitus recently announced quarterly report
Click to see if Mellitus had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mellitus, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Mellitus is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Mellitus has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mellitus launches new products
Funding: Get notified immidiatlly once Mellitus has new funding data
Recommended Actions
Find VP level buyers at Mellitus
Find more new buyers
Compare Similar Companies to Mellitus
Compare insights from companies similar to Mellitus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mellitus
<$5M
1-10
Private
<$5M
2011
N/A
Company Profile Activity
Activity Insights
Mellitus is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mellitus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mellitus.
Mellitus financials insights
Gather financial insights about Mellitus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$992K
2017
Debt
$2.1M
Mellitus Tech Stack
A closer look at the technologies used by Mellitus
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mellitus
Sign Up For FreeTo access detailed company insights
Mellitus is a private company that was founded to develop and commercialize a novel in vitro diagnostic assay for the measurement of Glycated CD59 (GCD59). GCD59 may provide information about glycemic control, with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk, and as a companion... Read More
